Universal Genomic Testing Needed to Win the War Against Cancer
Authors:
- 1 June 2016
- journal article
- viewpoint
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 2 (6) , 719-720
Abstract
This Viewpoint argues for universal tumor sequencing.Keywords
This publication has 6 references indexed in Scilit:
- Next-Generation Sequencing in Oncology in the Era of Precision MedicineJAMA Oncology, 2016
- Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical TrialsJournal of Clinical Oncology, 2015
- Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA ApprovalJNCI: Journal of the National Cancer Institute, 2015
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsNew England Journal of Medicine, 2015
- On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 PatientsMolecular Cancer Therapeutics, 2015
- Unique Molecular Landscapes in Cancer: Implications for Individualized, Curated Drug CombinationsCancer Research, 2014